TGF-β1-mediated differentiation of fibroblasts is associated with increased mitochondrial content and cellular respiration

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Negmadjanov, Ulugbek ^a   Godic, Zarko ^a   Rizvi, Farhan ^a   Emelyanova, Larisa ^a   Ross, Gracious ^a   Richards, John ^b   Holmuhamedov, Ekhson L ^a   Jahangir, Arshad ^a,b  

^a Aurora Health Care   (United States)

^b AURORA HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA SMOOTH MUSCLE ACTIN; GLUCOSE; MITOCHONDRIAL DNA; PYRUVIC ACID; TRANSFORMING GROWTH FACTOR BETA1; VOLTAGE DEPENDENT ANION CHANNEL; MESSENGER RNA; MITOCHONDRIAL PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL RESPIRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA CONTENT; FIBROBLAST; FIBROBLAST CULTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; MYOFIBROBLAST; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; STRESS FIBER; 3T3 CELL LINE; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL RESPIRATION; CELLS, CULTURED; FIBROBLASTS; IMMUNOENZYME TECHNIQUES; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NIH 3T3 CELLS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84927534750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123046     Document Type: Article

References (42)

1. Baum J, Duffy HS. (2011) Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol. 2011; 57:376-379. doi: 10.1097/FJC.0b013e3182116e39 PMID: 21297493
2. Honda E, Park AM, Yoshida K, Tabuchi M, Munakata H. Myofibroblasts: Biochemical and proteomic approaches to fibrosis. Tohoku J Exp Med. 2013; 230:67-73. PMID: 23774326
3. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology. 2006; 118:10-24. PMID: 16630019
4. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014; 71:549-574. doi: 10.1007/s00018-013-1349-6 PMID: 23649149
5. Baudino TA, McFadden A, Fix C, Hastings J, Price R, Borg TK. Cell patterning: interaction of cardiac myocytes and fibroblasts in three-dimensional culture. Microsc Microanal. 2008; 14:117-125. doi: 10.1017/S1431927608080021 PMID: 18312716
6. Corradi D, Callegari S, Maestri R, Benussi S, Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2008; 5:782-796. doi: 10.1038/ncpcardio1370 PMID: 18852714
7. Detillieux KA, Sheikh F, Kardami E, Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res. 2003; 57:8-19. PMID: 12504809
8. Noseda M, Schneider MD. Fibroblasts inform the heart: control of cardiomyocyte cycling and size by age-dependent paracrine signals. Dev Cell. 2009; 16:161-162. doi: 10.1016/j.devcel.2009.01.020 PMID: 19217417
9. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res. 2009; 105:1164-1176. doi: 10.1161/CIRCRESAHA.109.209809 PMID: 19959782
10. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3:349-363. PMID: 11988769
11. Baum JR, Long B, Cabo C, Duffy HS. Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct. Am J Physiol Heart Circ Physiol. 2012; 302:H790-H800. doi: 10.1152/ajpheart.00498.2011 PMID: 22101526
12. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002; 62:65-74. PMID: 12065756
13. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004; 63:423-432. PMID: 15276467
14. Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013; 10:15-26. doi: 10.1038/nrcardio.2012.158 PMID: 23207731
15. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9:671-675. PMID: 22930834
16. Holmuhamedov E, Lemasters JJ. Ethanol exposure decreases mitochondrial outer membrane permeability in cultured rat hepatocytes. Arch Biochem Biophys. 2009; 481:226-233. doi: 10.1016/j.abb. 2008.10.036 PMID: 19014900
17. Holmuhamedov EL, Czerny C, Beeson CC, Lemasters JJ. Ethanol suppresses ureagenesis in rat hepatocytes: role of acetaldehyde. J Biol Chem. 2012; 287:7692-7700. doi: 10.1074/jbc.M111.293399 PMID: 22228763
18. Biovision Inc. Mitochondrial DNA Isolation Kit. Available: http://www.biovision.com/mitochondrial-dna-isolation-kit-2835.html. See PDF Data Sheet in Product Toolbox. Accessed 2015 Feb 17.
19. Gerencser AA, Neilson A, Choi SW, Edman U, Yadava N, Oh RJ, et al. Quantitative microplate-based respirometry with correction for oxygen diffusion. Anal Chem. 2009; 81:6868-6878. doi: 10.1021/ac900881z PMID: 19555051
20. Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA, et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One 2011; 6: e21746. doi: 10.1371/journal.pone.0021746 PMID: 21799747
21. Chen W, Frangogiannis NG. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta. 2013; 1833:945-953. doi: 10.1016/j.bbamcr.2012.08.023 PMID: 22982064
22. Van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010; 7:30-37. doi: 10.1038/nrcardio.2009.199 PMID: 19949426
23. Daskalopoulos EP, Janssen BJ, Blankesteijn WM. Targeting Wnt signaling to improve wound healing after myocardial infarction. Methods Mol Biol. 2013; 1037:355-380. doi: 10.1007/978-1-62703-505-7-21 PMID: 24029947
24. Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010; 225:631-637. doi: 10.1002/jcp.22322 PMID: 20635395
25. Chiang B, Essick E, Ehringer W, Murphree S, Hauck MA, Li M, et al. Enhancing skin wound healing by direct delivery of intracellular adenosine triphosphate. Am J Surg. 2007; 193:213-218. Erratum in: Am J Surg. 2008;195:139. PMID: 17236849
26. Wang DJ, Huang NN, Heppel LA. Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters. Biochem Biophys Res Commun. 1990; 166:251-258. PMID: 1967937
27. Dzeja PP, Holmuhamedov EL, Ozcan C, Pucar D, Jahangir A, Terzic A. Mitochondria: gateway for cytoprotection. Circ Res. 2001; 89:744-746. PMID: 11679401
28. Holmuhamedov EL, Oberlin A, Short K, Terzic A, Jahangir A. Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide. PLoS One 2012; 7:e44667. doi: 10.1371/journal.pone.0044667 PMID: 22973464
29. Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, et al. Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev. 2008; 129:304-312. doi: 10.1016/j.mad.2008.02.010 PMID: 18400259
30. Moruzzi N, Del Sole M, Fato R, Gerdes JM, Berggren PO, Bergamini C, et al. Short and prolonged exposure to hyperglycaemia in human fibroblasts and endothelial cells: metabolic and osmotic effects. Int J Biochem Cell Biol. 2014; 53:66-76. doi: 10.1016/j.biocel.2014.04.026 PMID: 24814290
31. Baracca A, Sgarbi G, Padula A, Solaini G. Glucose plays a main role in human fibroblasts adaptation to hypoxia. Int J Biochem Cell Biol. 2013; 45:1356-1365. doi: 10.1016/j.biocel.2013.03.013 PMID: 23538299
32. Solmi R, Pallotti F, Rugolo M, Genova ML, Estornell E, Ghetti P, et al. Lack of major mitochondrial bioenergetic changes in cultured skin fibroblasts from aged individuals. Biochem Mol Biol Int. 1994; 33:477-484. PMID: 7951066
33. Friedman JR, Nunnari J. Mitochondrial form and function. Nature. 2014; 505:335-343. doi: 10.1038/nature12985 PMID: 24429632
34. Nemutlu E, Zhang S, Gupta A, Juranic NO, Macura SI, Terzic A, et al. Dynamic phosphometabolomic profiling of human tissues and transgenic models by 18O-assisted 31P NMR and mass spectrometry. Physiol Genomics. 2012; 44:386-402. doi: 10.1152/physiolgenomics.00152.2011 PMID: 22234996
35. Pereira SL, Ramalho-Santos J, Branco AF, Sardão VA, Oliveira PJ, Carvalho RA. Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies. Cardiovasc Toxicol. 2011; 11:180-190. doi: 10.1007/s12012-011-9112-4 PMID: 21431998
36. McNulty AK, Schmidt M, Feeley T, Villanueva P, Kieswetter K. Effects of negative pressure wound therapy on cellular energetics in fibroblasts grown in a provisional wound (fibrin) matrix. Wound Repair Regen. 2009; 17:192-199. doi: 10.1111/j.1524-475X.2009.00460.x PMID: 19320887
37. Gout E, Rebeille F, Douce R, Bligny R. Interplay of Mg2+, ADP, and ATP in the cytosol and mitochondria: unravelling the role of Mg2+ in cell respiration. Proc Natl Acad Sci U S A. 2014; 111:E4560-4567. doi: 10.1073/pnas.1406251111 PMID: 25313036
38. McNulty AK, Schmidt M, Feeley T, Kieswetter K. Effects of negative pressure wound therapy on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix. Wound Repair Regen. 2007; 15:838-846. PMID: 18028132
39. Langevin HM, Bouffard NA, Badger GJ, Iatridis JC, Howe AK. Dynamic fibroblast cytoskeletal response to subcutaneous tissue stretch ex vivo and in vivo. Am J Physiol Cell Physiol. 2005; 288:C747-C756. PMID: 15496476
40. Furuya S, Furuya K. Roles of substance P and ATP in the subepithelial fibroblasts of rat intestinal villi. Int Rev Cell Mol Biol. 2013; 304:133-189. doi: 10.1016/B978-0-12-407696-9.00003-8 PMID: 23809436
41. Fillmore N, Mori J, Lopaschuk GD. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br J Pharmacol. 2014; 171:2080-2090. doi: 10.1111/bph.12475 PMID: 24147975
42. Zhou L, Huang H, McElfresh TA, Prosdocimo DA, Stanley WC. Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia. Am J Physiol Heart Circ Physiol. 2008; 295:H939-H945. doi: 10.1152/ajpheart.00561.2008 PMID: 18660443